scispace - formally typeset
G

Ghislain Rocheleau

Researcher at McGill University

Publications -  27
Citations -  9255

Ghislain Rocheleau is an academic researcher from McGill University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 12, co-authored 18 publications receiving 8635 citations. Previous affiliations of Ghislain Rocheleau include Icahn School of Medicine at Mount Sinai & Centre national de la recherche scientifique.

Papers
More filters
Journal ArticleDOI

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

Josée Dupuis, +339 more
- 01 Feb 2010 - 
TL;DR: It is demonstrated that genetic studies of glycemic traits can identify type 2 diabetes risk loci, as well as loci containing gene variants that are associated with a modest elevation in glucose levels but are not associated with overt diabetes.
Journal ArticleDOI

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

Benjamin F. Voight, +183 more
- 01 Jul 2010 - 
TL;DR: By combining genome-wide association data from 8,130 individuals with type 2 diabetes and 38,987 controls of European descent and following up previously unidentified meta-analysis signals, 12 new T2D association signals are identified with combined P < 5 × 10−8.
Journal ArticleDOI

A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk

TL;DR: The data suggest a possible link between circadian rhythm regulation and glucose homeostasis through the melatonin signaling pathway and show MT2 expression in human pancreatic islets and beta cells.
Journal ArticleDOI

Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

Zari Dastani, +618 more
- 29 Mar 2012 - 
TL;DR: A meta-analysis of genome-wide association studies in 39,883 individuals of European ancestry to identify genes associated with metabolic disease identifies novel genetic determinants of adiponectin levels, which, taken together, influence risk of T2D and markers of insulin resistance.